|
시장보고서
상품코드
1673849
AGE(Advanced Glycation End) 제품 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Advanced Glycation End Products Market, By Type, By Application, By End User, By Geography |
||||||
세계의 AGE(Advanced Glycation End) 제품 시장은 2025년에 18억 7,000만 달러로 추정되며, 2032년에는 30억 1,000만 달러에 달할 것으로 예측되며, 2025-2032년 연간 평균 성장률(CAGR)은 7.0%로 성장할 전망입니다.
| 보고 범위 | 보고서 상세 내용 | ||
|---|---|---|---|
| 기준연도 | 2024년 | 2025년 시장 규모 | 18억 7,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR | 7.00% | 2032년 금액 예측 | 30억 1,000만 달러 |
AGEs는 환원당 또는 탄수화물과 단백질 또는 지질 사이의 비효소 반응의 결과로 체내에서 형성되는 분자로, AGEs가 체내에 축적되면 산화 스트레스와 염증이 증가하여 다양한 만성질환의 위험을 증가시킵니다. 및 염증이 증가하여 다양한 만성질환의 위험을 높입니다. 건강에 대한 인식이 높아짐에 따라 혁신적인 AGE 억제 요법 개발에 초점을 맞춘 연구개발이 증가하고, AGE 측정 툴 및 노화 관련 증상을 효과적으로 관리할 수 있는 약물에 대한 수요가 증가할 것으로 예상됩니다.
시장 역학
당뇨병 및 기타 생활습관병 환자 증가, 만성질환에 취약한 고령화 인구 증가 시장 개발에 따른 의료비 증가, 보다 효과적인 AGE 억제제 개발을 위한 R&D 진행 등이 세계 당화 최종제품 시장 성장의 원동력이 되고 있습니다. 그러나 AGE 검출 기술과 관련된 높은 비용과 낮은 인지도가 시장 성장의 걸림돌로 작용할 수 있습니다. 저비용의 Point-of-Care AGE 측정장비 개발, 연구기관과의 협력체계 구축, 신흥 국가 시장으로의 진출 등이 시장 개발의 기회가 될 수 있습니다.
본 조사의 주요 특징
세계의 AGE(Advanced Glycation End) 제품 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측기간(2025-2032년) 동안 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 게재하고 있습니다.
이 보고서는 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 AGE(Advanced Glycation End) 제품 시장의 주요 기업을 프로파일링합니다.
본 조사의 대상이 되는 주요 기업에는 Keryx Biopharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Amrax Bio 등이 포함됩니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
세계 AGE(Advanced Glycation End) 제품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 AGE(Advanced Glycation End) 제품 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 리포트 설명
- 시장의 정의와 범위
- 개요
- COM(Coherent Opportunity Map)(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 촉진요인
- 억제요인
- 기회
- 영향 분석
- 시장 동향
- 규제 시나리오
- 인수와 제휴 시나리오
- 자금조달과 투자
- PEST 분석
- Porter의 산업 분석
제4장 세계의 AGE(Advanced Glycation End) 제품 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 구상
- 시장에 대한 COVID-19의 영향
제5장 세계의 AGE(Advanced Glycation End) 제품 시장, 유형별, 2020-2032년(10억 달러)
- 서론
- 비형광
- 형광
제6장 세계의 AGE(Advanced Glycation End) 제품 시장, 용도별, 2020-2032년(10억 달러)
- 서론
- 당뇨병 합병증
- 암
- 뼈질환
- 신경변성질환
- 기타
제7장 세계의 AGE(Advanced Glycation End) 제품 시장, 최종사용자별, 2020-2032년(10억 달러)
- 서론
- 병원
- 전문 클리닉
- 재택 의료
- 기타
제8장 세계의 AGE(Advanced Glycation End) 제품 시장, 지역별, 2020-2032년(10억 달러)
- 서론
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- 기업 개요
- Alteon Inc.
- Plexxikon Inc.
- Phenomenome Discoveries Inc.
- Kowa Company Ltd.
- Novartis International AG
- OPKO Health, Inc.
- DiabetOmics, Inc.
- Amadori Scientific
- LabCorp
- Quest Diagnostics Incorporated
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Eli Lilly and Company
- Sanofi SA
제10장 애널리스트의 권장사항
- 운명의 수레바퀴
- COM(Coherent Opportunity Map)
제11장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
Global Advanced Glycation End Products Market is estimated to be valued at USD 1.87 Bn in 2025 and is expected to reach USD 3.01 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1.87 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.00% | 2032 Value Projection: | USD 3.01 Bn |
Global advanced glycation end products market growth is driven by increasing prevalence of diabetes and hypertension coupled with rising geriatric population worldwide. AGEs are molecules formed internally in the body as a result of non-enzymatic reactions between reducing sugars or carbohydrates and proteins or lipids. Accumulation of AGEs in the body causes damage by increasing oxidative stress and inflammation which can increase the risk of various chronic diseases. Due to growing health awareness, more research studies focusing on developing innovative AGE inhibition therapies can boost demand for AGE measurement tools and drugs to manage age-related conditions effectively.
Market Dynamics:
Global advanced glycation end products market growth is driven by factors like rising cases of diabetes and other lifestyle-related disorders, increasing aging population susceptible to chronic diseases, growing healthcare expenditure in developing nations, and ongoing research efforts to develop more effective AGE inhibitors. However, high costs associated with AGE detection technologies and lack of awareness can hamper the market growth. Developing low-cost point-of-care AGE measurement devices, establishing collaboration with research institutes, and expanding to emerging regions can offer opportunities for market players.
Key Features of the Study:
This report provides in-depth analysis of the global advanced glycation end products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global advanced glycation end products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Keryx Biopharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Amrax Bio, and others
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global advanced glycation end products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced glycation end products market
Detailed Segmentation-
- By Type
- Non-fluorescent AGEs
- Fluorescent AGEs
- By Application
- Diabetic Complications
- Cancer
- Bone Diseases
- Neurodegenerative Diseases
- Others
- By End User
- Hospitals
- Specialty Clinics
- Homecare Settings
- Other
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Alteon Inc.
- Plexxikon Inc.
- Phenomenome Discoveries Inc.
- Kowa Company Ltd.
- Novartis International AG
- OPKO Health, Inc.
- DiabetOmics, Inc.
- Amadori Scientific
- LabCorp
- Quest Diagnostics Incorporated
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Eli Lilly and Company
- Sanofi S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Advanced Glycation End Products Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Advanced Glycation End Products Market, By Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Non-fluorescent AGEs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fluorescent AGEs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Advanced Glycation End Products Market, By Application, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diabetic Complications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bone Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurodegenerative Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Advanced Glycation End Products Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Advanced Glycation End Products Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Alteon Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Plexxikon Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Phenomenome Discoveries Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kowa Company Ltd.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis International AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OPKO Health, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DiabetOmics, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amadori Scientific
- LabCorp
- Quest Diagnostics Incorporated
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Eli Lilly and Company
- Sanofi S.A.
- Alteon Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Reference and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
